vs

Side-by-side financial comparison of PETMED EXPRESS INC (PETS) and SolarMax Technology, Inc. (SMXT). Click either name above to swap in a different company.

SolarMax Technology, Inc. is the larger business by last-quarter revenue ($46.6M vs $40.7M, roughly 1.1× PETMED EXPRESS INC). SolarMax Technology, Inc. runs the higher net margin — -1.9% vs -26.0%, a 24.1% gap on every dollar of revenue. On growth, SolarMax Technology, Inc. posted the faster year-over-year revenue change (623.5% vs -23.3%).

PetMed Express, Inc., also known as PetMeds, is an online pet pharmacy based in the United States. It is publicly traded and sells prescription and non-prescription pet medication.

SolarMax Technology, Inc. develops, manufactures and sells high-efficiency solar PV modules and clean energy systems. It serves residential, commercial and industrial clients in North America and key Asia-Pacific markets, offering installation and after-sales support to boost low-carbon energy use.

PETS vs SMXT — Head-to-Head

Bigger by revenue
SMXT
SMXT
1.1× larger
SMXT
$46.6M
$40.7M
PETS
Growing faster (revenue YoY)
SMXT
SMXT
+646.7% gap
SMXT
623.5%
-23.3%
PETS
Higher net margin
SMXT
SMXT
24.1% more per $
SMXT
-1.9%
-26.0%
PETS

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
PETS
PETS
SMXT
SMXT
Revenue
$40.7M
$46.6M
Net Profit
$-10.6M
$-872.2K
Gross Margin
23.3%
2.7%
Operating Margin
-25.7%
-2.7%
Net Margin
-26.0%
-1.9%
Revenue YoY
-23.3%
623.5%
Net Profit YoY
-1392.6%
77.7%
EPS (diluted)
$-0.50
$-0.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PETS
PETS
SMXT
SMXT
Q4 25
$40.7M
$46.6M
Q3 25
$44.4M
$30.6M
Q2 25
$51.2M
$6.9M
Q1 25
$50.8M
$6.9M
Q4 24
$52.0M
$6.4M
Q3 24
$58.0M
$6.3M
Q2 24
$66.2M
Q1 24
$65.1M
Net Profit
PETS
PETS
SMXT
SMXT
Q4 25
$-10.6M
$-872.2K
Q3 25
$-8.5M
$-2.3M
Q2 25
$-34.2M
$-1.9M
Q1 25
$-11.6M
$-1.3M
Q4 24
$-707.0K
$-3.9M
Q3 24
$2.3M
$-9.6M
Q2 24
$3.8M
Q1 24
$-5.0M
Gross Margin
PETS
PETS
SMXT
SMXT
Q4 25
23.3%
2.7%
Q3 25
28.0%
3.1%
Q2 25
28.1%
8.8%
Q1 25
29.9%
20.5%
Q4 24
31.0%
14.5%
Q3 24
32.3%
19.9%
Q2 24
28.8%
Q1 24
29.3%
Operating Margin
PETS
PETS
SMXT
SMXT
Q4 25
-25.7%
-2.7%
Q3 25
-18.9%
-6.9%
Q2 25
-66.7%
-25.7%
Q1 25
-11.9%
-16.7%
Q4 24
-0.9%
-27.9%
Q3 24
1.0%
-158.4%
Q2 24
6.6%
Q1 24
-5.9%
Net Margin
PETS
PETS
SMXT
SMXT
Q4 25
-26.0%
-1.9%
Q3 25
-19.2%
-7.4%
Q2 25
-66.7%
-27.6%
Q1 25
-22.9%
-18.7%
Q4 24
-1.4%
-60.6%
Q3 24
4.0%
-152.0%
Q2 24
5.7%
Q1 24
-7.7%
EPS (diluted)
PETS
PETS
SMXT
SMXT
Q4 25
$-0.50
$-0.02
Q3 25
$-0.41
$-0.04
Q2 25
$-1.65
$-0.04
Q1 25
$-0.56
$-0.03
Q4 24
$-0.03
$-0.07
Q3 24
$0.11
$-0.21
Q2 24
$0.18
Q1 24
$-0.24

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PETS
PETS
SMXT
SMXT
Cash + ST InvestmentsLiquidity on hand
$26.9M
$8.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$32.8M
$-12.2M
Total Assets
$88.0M
$91.3M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PETS
PETS
SMXT
SMXT
Q4 25
$26.9M
$8.0M
Q3 25
$36.1M
$5.7M
Q2 25
$41.1M
$1.9M
Q1 25
$54.7M
$6.8M
Q4 24
$50.1M
$7.1M
Q3 24
$52.0M
$8.6M
Q2 24
$46.0M
Q1 24
$55.3M
Stockholders' Equity
PETS
PETS
SMXT
SMXT
Q4 25
$32.8M
$-12.2M
Q3 25
$43.1M
$-11.8M
Q2 25
$51.5M
$-15.1M
Q1 25
$85.1M
$-15.9M
Q4 24
$96.2M
$-15.1M
Q3 24
$96.4M
$-10.9M
Q2 24
$93.5M
Q1 24
$96.7M
Total Assets
PETS
PETS
SMXT
SMXT
Q4 25
$88.0M
$91.3M
Q3 25
$100.3M
$58.7M
Q2 25
$109.8M
$38.2M
Q1 25
$148.7M
$38.6M
Q4 24
$144.8M
$38.6M
Q3 24
$146.0M
$43.0M
Q2 24
$152.7M
Q1 24
$169.9M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PETS
PETS
SMXT
SMXT
Operating Cash FlowLast quarter
$-9.2M
$-2.5M
Free Cash FlowOCF − Capex
$-9.2M
FCF MarginFCF / Revenue
-22.7%
Capex IntensityCapex / Revenue
0.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-23.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PETS
PETS
SMXT
SMXT
Q4 25
$-9.2M
$-2.5M
Q3 25
$-2.2M
$3.4M
Q2 25
$-12.3M
$220.7K
Q1 25
$7.0M
$-601.1K
Q4 24
$-1.2M
$-1.3M
Q3 24
$7.4M
$203.6K
Q2 24
$-8.5M
Q1 24
$7.1M
Free Cash Flow
PETS
PETS
SMXT
SMXT
Q4 25
$-9.2M
Q3 25
$-4.8M
Q2 25
$-13.6M
Q1 25
$4.6M
Q4 24
$-1.9M
Q3 24
$6.1M
Q2 24
$-9.2M
Q1 24
$5.9M
FCF Margin
PETS
PETS
SMXT
SMXT
Q4 25
-22.7%
Q3 25
-10.8%
Q2 25
-26.5%
Q1 25
9.1%
Q4 24
-3.7%
Q3 24
10.6%
Q2 24
-13.9%
Q1 24
9.0%
Capex Intensity
PETS
PETS
SMXT
SMXT
Q4 25
0.1%
Q3 25
5.9%
Q2 25
2.5%
Q1 25
4.7%
Q4 24
1.5%
Q3 24
2.2%
0.0%
Q2 24
1.0%
Q1 24
1.9%
Cash Conversion
PETS
PETS
SMXT
SMXT
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
3.18×
Q2 24
-2.27×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PETS
PETS

Reorder$34.0M84%
New Order$5.0M12%
Membership Fees$1.6M4%

SMXT
SMXT

Yabucoa$35.9M77%
Other$10.7M23%

Related Comparisons